Pfizer agrees to license generic versions of its COVID-19 pill — in some countries
The agreement covers 95 nations, but it omits hard-hit countries such as Russia, Turkey, Brazil, and Mexico. Pfizer said it is seeking authorization for emergency use of the medication in the U.S.